Seroprevalence of pertussis in China: need to improve vaccination strategies. - Test2 - elhamkhani - TriplyDB

Seroprevalence of pertussis in China: need to improve vaccination strategies.

Seroprevalence of pertussis in China: need to improve vaccination strategies.

http://www.wikidata.org/entity/Q34271536

about

Is Pertussis Infection Neglected in China? Evidence from a Seroepidemiology Survey in Zhejiang, an Eastern Province of China The efficacy of QingfengGanke granule in treating postinfectious cough in pathogenic wind invading lungs syndrome: a multicenter, randomized, double-blind, placebo-controlled trial Pertussis. A reemerging and an underreported infectious disease.Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study.Bordetella pertussis fimbriae (Fim): relevance for vaccines.Seroprevalence studies of pertussis: what have we learned from different immunized populations.Brief Report: Seroprevalence of Pertussis Infection in HIV-Infected Adults in the United States.Seroprevalence of Maternal and Cord Antibodies Specific for Diphtheria, Tetanus, Pertussis, Measles, Mumps and Rubella in Shunyi, Beijing

P2860

Q28552431-8A094027-5696-4C5C-A712-6FB692AD6885 Q30405105-500EE916-8300-4F26-8A94-48D8A9E2B1B3 Q35183514-0932962D-686E-41C6-AD9A-084112FF8FBA Q36334529-CDCC3CE6-E635-4B1A-95FA-9F625116A989 Q38237862-CD713B73-B15D-4E31-81BD-08042C643721 Q38553680-F7DADA74-D6D7-4152-9838-CC7642E5A8FC Q40703210-C862AF44-D1E6-472A-8507-1E7BD0BDBA65 Q58695481-E8D1B415-9E5B-471D-8D4C-9CBD529FCC72

P2860

Seroprevalence of pertussis in China: need to improve vaccination strategies.

http://www.wikidata.org/entity/Q34271536

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Seroprevalence of pertussis in China: need to improve vaccination strategies.

@ast

Seroprevalence of pertussis in China: need to improve vaccination strategies.

@en

Seroprevalence of pertussis in China: need to improve vaccination strategies.

@nl

type

label

Seroprevalence of pertussis in China: need to improve vaccination strategies.

@ast

Seroprevalence of pertussis in China: need to improve vaccination strategies.

@en

Seroprevalence of pertussis in China: need to improve vaccination strategies.

@nl

prefLabel

Seroprevalence of pertussis in China: need to improve vaccination strategies.

@ast

Seroprevalence of pertussis in China: need to improve vaccination strategies.

@en

Seroprevalence of pertussis in China: need to improve vaccination strategies.

@nl

P1433

Q34271536-E2CF7483-1FD5-4C4D-A2CD-B31C89BB9608

P1476

Q34271536-D45F27D8-2199-426C-B44C-579CEC1EE54E

P2093

Q34271536-3C524272-78D7-4C20-8EE2-9D9AD4CC4991

Q34271536-7061261A-B0DC-4DA9-9296-5FB9735D3D45

Q34271536-713631F1-1F48-4E88-B3F9-5D737DFF4147

Q34271536-978CB530-A834-465A-B32D-C0F08B19D305

Q34271536-A0ECFE10-12C2-4BFA-94D1-E09E4B12ED4B

Q34271536-AE439461-5B79-4B1D-8AFA-40EF8E5FA70D

Q34271536-B94511D6-390F-4C8C-953B-778BC583DA24

Q34271536-D1BBFDD8-23A2-40F0-B93B-3F97E988EE19

Q34271536-DB312D79-EA5D-4266-A710-0A497FC396CE

P2860

Q34271536-01225C1D-0853-45ED-8329-9F6CF89C2820

Q34271536-01C64031-65B4-4E63-8A59-8E9A482B314E

Q34271536-02AFDA88-F804-4617-B28F-F9E9CE233943

Q34271536-19BE2387-4C88-45FC-BA85-629698B42368

Q34271536-21A57474-4A34-4694-B736-B94E06653D10

Q34271536-262DE1E8-C4DA-4F9B-B66E-B6A4C86191D6

Q34271536-27DE26EF-01BC-4A02-A99F-30EF11826095

Q34271536-2A05C8BF-242C-49A4-A13E-6EB64819D2DF

Q34271536-31A805A7-20C7-4670-A0B8-B42B25018671

Q34271536-35D2F293-4736-4D83-89D4-8AD782EBD979

P304

Q34271536-78183D14-CB26-43F2-8A93-8D7C93F853D2

P31

Q34271536-6771F4B8-2328-4494-B383-4BA9E8609CF4

P356

Q34271536-A119ECED-E01F-433A-87D6-FAB6006736C3

P433

Q34271536-F33DA434-FA95-4CBC-B447-559FD129819C

P478

Q34271536-9AE3732A-101A-467C-8DFA-2DD75B7FDE83

P577

Q34271536-E5223B77-2E84-4784-8D16-00A63350E200

P698

Q34271536-8AC644FA-EBFB-46DE-9FC3-334D1B2A9441

P921

Q34271536-98D640FF-3061-44AE-B7C6-B60A50080AAC

P932

Q34271536-236E0270-0458-49DB-8C8D-743E86307CD1

P356

P1433

Human Vaccines & Immunotherapeutics

P1476

Seroprevalence of pertussis in China: need to improve vaccination strategies.

@en

P2093

Chen Wei

http://www.w3.org/2001/XMLSchema#string

Jin Xu

http://www.w3.org/2001/XMLSchema#string

Junzhi Wang

http://www.w3.org/2001/XMLSchema#string

Lichan Wang

http://www.w3.org/2001/XMLSchema#string

Peng Luo

http://www.w3.org/2001/XMLSchema#string

Qiming Hou

http://www.w3.org/2001/XMLSchema#string

Xiao Ma

http://www.w3.org/2001/XMLSchema#string

Xinjian Wang

http://www.w3.org/2001/XMLSchema#string

Yinghua Xu

http://www.w3.org/2001/XMLSchema#string

P2860

The European Sero-Epidemiology Network 2 (ESEN2): standardization of assay results for hepatitis A virus (HAV) to enable comparisons of seroprevalence data across 15 countries.

A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity.

Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis

Sero-epidemiology as a tool to screen populations for exposure to Mycobacterium ulcerans.

The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study.

Duration of immunity against pertussis after natural infection or vaccination.

What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories

Vaccination recommendations for Germany.

Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine.

P304

192-198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/HV.26335

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24018405

http://www.w3.org/2001/XMLSchema#string

P921

P932

4181022

http://www.w3.org/2001/XMLSchema#string